-+ 0.00%
-+ 0.00%
-+ 0.00%

3D Medicines schedules board meeting to review interim results, consider dividend

PUBT·08/17/2026 13:27:34
Listen to the news
3D Medicines schedules board meeting to review interim results, consider dividend
  • 3D Medicines scheduled a board meeting for Aug. 31, 2026.
  • Unaudited interim results for the six months ended June 30, 2026 set for review.
  • Interim dividend decision also slated for consideration.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 3D Medicines Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260817-12287483), on August 17, 2026, and is solely responsible for the information contained therein.